PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today that senior company executives will present at five key industry conferences in ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
PanGen Biotech, a biopharmaceutical subsidiary of Huons Group, reported record-high revenue last year after growth in its biosimilar business took off across the globe. Annual sales were 14.67 billion ...
With Northway Biotech's expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market by delivering a safe ...
A study reveals a widening life expectancy gap by education level in the US, emphasizing the need for equitable access to ...
Bill Stern, a partner in Goodwin Procter’s financial services practice, said the “pendulum” of regulation is due to swing ...
Rep. Andy Ogles (R-Tenn.) proposed an amendment to the U.S. Constitution that would allow President Trump to serve a third ...
Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "USA Directory of Biotechnology Companies 2025" has been added to ResearchAndMarkets.com's offering. The new USA Directory of Biotechnology Companies is ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "USA Directory of Biotechnology Companies 2025" has been added to ResearchAndMarkets.com's offering. The new USA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback